Rolf F. Barth - Publications

Affiliations: 
 

64 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Barth RF, Carpenter DE. Rodent Brain Tumor Models for Studies Focusing on Boron Neutron Capture Therapy. Cancer Biotherapy & Radiopharmaceuticals. PMID 36125407 DOI: 10.1089/cbr.2022.0041  0.449
2022 Sahu U, Barth RF, Otani Y, McCormack R, Kaur B. Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research. Journal of Neuropathology and Experimental Neurology. PMID 35446393 DOI: 10.1093/jnen/nlac021  0.411
2020 Wang JL, Barth RF, Cavaliere R, Puduvalli VK, Giglio P, Lonser RR, Elder JB. Phase I trial of intracerebral convection-enhanced delivery of carboplatin for treatment of recurrent high-grade gliomas. Plos One. 15: e0244383. PMID 33373402 DOI: 10.1371/journal.pone.0244383  0.337
2020 Elleaume H, Barth RF, Rousseau J, Bobyk L, Balosso J, Yang W, Huo T, Nakkula R. Radiation therapy combined with intracerebral convection-enhanced delivery of cisplatin or carboplatin for treatment of the F98 rat glioma. Journal of Neuro-Oncology. PMID 32809095 DOI: 10.1007/s11060-020-03600-x  0.355
2018 Barth RF, Zhang Z, Liu T. A realistic appraisal of boron neutron capture therapy as a cancer treatment modality. Cancer Communications (London, England). 38: 36. PMID 29914575 DOI: 10.1186/s40880-018-0280-5  0.303
2016 Barth RF, Wu G, Meisen WH, Nakkula RJ, Yang W, Huo T, Kellough DA, Kaumaya P, Turro C, Agius LM, Kaur B. Design, synthesis, and evaluation of cisplatin-containing EGFR targeting bioconjugates as potential therapeutic agents for brain tumors. Oncotargets and Therapy. 9: 2769-2781. PMID 27274273 DOI: 10.2147/Ott.S99242  0.383
2016 Barth RF, Wu G, Hans Meisen W, Nakkula RJ, Yang W, Huo T, Kellough DA, Kaumaya P, Turro C, Agius LM, Kaur B. Design, synthesis, and evaluation of cisplatin-containing EGFR targeting bioconjugates as potential therapeutic agents for brain tumors Oncotargets and Therapy. 9: 2769-2781. DOI: 10.2147/OTT.S99242  0.381
2015 Chandra S, Parker DJ, Barth RF, Pannullo SC. Quantitative imaging of magnesium distribution at single-cell resolution in brain tumors and infiltrating tumor cells with secondary ion mass spectrometry (SIMS). Journal of Neuro-Oncology. PMID 26703785 DOI: 10.1007/s11060-015-2022-8  0.361
2015 Barth RF, Yang W, Nakkula RJ, Byun Y, Tjarks W, Chu Wu L, Binns PJ, Riley KJ. Evaluation of TK1 targeting carboranyl thymidine analogs as potential delivery agents for neutron capture therapy of brain tumors. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. PMID 26282567 DOI: 10.1016/j.apradiso.2015.06.031  0.371
2014 Yang W, Barth RF, Huo T, Nakkula RJ, Weldon M, Gupta N, Agius L, Grecula JC. Radiation therapy combined with intracerebral administration of carboplatin for the treatment of brain tumors. Radiation Oncology (London, England). 9: 25. PMID 24422671 DOI: 10.1186/1748-717X-9-25  0.374
2013 Chandra S, Barth RF, Haider SA, Yang W, Huo T, Shaikh AL, Kabalka GW. Biodistribution and subcellular localization of an unnatural boron-containing amino acid (cis-ABCPC) by imaging secondary ion mass spectrometry for neutron capture therapy of melanomas and gliomas. Plos One. 8: e75377. PMID 24058680 DOI: 10.1371/Journal.Pone.0075377  0.376
2012 Huo T, Barth RF, Yang W, Nakkula RJ, Koynova R, Tenchov B, Chaudhury AR, Agius L, Boulikas T, Elleaume H, Lee RJ. Preparation, biodistribution and neurotoxicity of liposomal cisplatin following convection enhanced delivery in normal and F98 glioma bearing rats. Plos One. 7: e48752. PMID 23152799 DOI: 10.1371/journal.pone.0048752  0.411
2011 Barth RF, Yang W, Huo T, Riley KJ, Binns PJ, Grecula JC, Gupta N, Rousseau J, Elleaume H. Comparison of intracerebral delivery of carboplatin and photon irradiation with an optimized regimen for boron neutron capture therapy of the F98 rat glioma. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 69: 1813-6. PMID 21493080 DOI: 10.1016/j.apradiso.2011.03.019  0.394
2011 Kawabata S, Yang W, Barth RF, Wu G, Huo T, Binns PJ, Riley KJ, Ongayi O, Gottumukkala V, Vicente MG. Convection enhanced delivery of carboranylporphyrins for neutron capture therapy of brain tumors. Journal of Neuro-Oncology. 103: 175-85. PMID 20848301 DOI: 10.1007/S11060-010-0376-5  0.467
2011 Yang W, Huo T, Barth RF, Gupta N, Weldon M, Grecula JC, Ross BD, Hoff BA, Chou TC, Rousseau J, Elleaume H. Convection enhanced delivery of carboplatin in combination with radiotherapy for the treatment of brain tumors. Journal of Neuro-Oncology. 101: 379-90. PMID 20577779 DOI: 10.1007/s11060-010-0272-z  0.411
2010 Rousseau J, Barth RF, Fernandez M, Adam JF, Balosso J, Estève F, Elleaume H. Efficacy of intracerebral delivery of cisplatin in combination with photon irradiation for treatment of brain tumors. Journal of Neuro-Oncology. 98: 287-95. PMID 20012464 DOI: 10.1007/s11060-009-0074-3  0.427
2010 Zhang H, Huo T, Barth R. SU-GG-T-123: Theoretical and Experimental Determination of Therapeutic Advantage of Single Fraction Megavoltage Grid Therapy for F98 Glioma Brain Tumor Cell Lines Medical Physics. 37: 3212-3213. DOI: 10.1118/1.3468512  0.343
2010 Yang W, Huo T, Barth RF, Gupta N, Weldon M, Grecula JC, Ross BD, Hoff BA, Chou T, Rousseau J, Elleaume H. Erratum to: Convection enhanced delivery of carboplatin in combination with radiotherapy for the treatment of brain tumors Journal of Neuro-Oncology. 101: 391-391. DOI: 10.1007/s11060-010-0316-4  0.364
2009 Yang W, Barth RF, Wu G, Huo T, Tjarks W, Ciesielski M, Fenstermaker RA, Ross BD, Wikstrand CJ, Riley KJ, Binns PJ. Convection enhanced delivery of boronated EGF as a molecular targeting agent for neutron capture therapy of brain tumors. Journal of Neuro-Oncology. 95: 355-65. PMID 19588228 DOI: 10.1007/s11060-009-9945-x  0.442
2009 Rousseau J, Adam JF, Deman P, Wu TD, Guerquin-Kern JL, Gouget B, Barth RF, Estve F, Elleaume H. Intracerebral delivery of 5-iodo-2′-deoxyuridine in combination with synchrotron stereotactic radiation for the therapy of the F98 glioma Journal of Synchrotron Radiation. 16: 573-581. PMID 19535873 DOI: 10.1107/S0909049509016987  0.351
2009 Yang W, Barth RF, Wu G, Tjarks W, Binns P, Riley K. Boron neutron capture therapy of EGFR or EGFRvIII positive gliomas using either boronated monoclonal antibodies or epidermal growth factor as molecular targeting agents. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 67: S328-31. PMID 19467880 DOI: 10.1016/j.apradiso.2009.03.030  0.385
2009 Barth RF. Boron neutron capture therapy at the crossroads: challenges and opportunities. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 67: S3-6. PMID 19467879 DOI: 10.1016/j.apradiso.2009.03.102  0.382
2009 Barth RF, Kaur B. Rat brain tumor models in experimental neuro-oncology: the C6, 9L, T9, RG2, F98, BT4C, RT-2 and CNS-1 gliomas. Journal of Neuro-Oncology. 94: 299-312. PMID 19381449 DOI: 10.1007/S11060-009-9875-7  0.436
2009 Rousseau J, Barth RF, Moeschberger ML, Elleaume H. Efficacy of intracerebral delivery of Carboplatin in combination with photon irradiation for treatment of F98 glioma-bearing rats. International Journal of Radiation Oncology, Biology, Physics. 73: 530-6. PMID 19147017 DOI: 10.1016/J.Ijrobp.2008.09.018  0.315
2008 Barth RF, Yang W, Wu G, Swindall M, Byun Y, Narayanasamy S, Tjarks W, Tordoff K, Moeschberger ML, Eriksson S, Binns PJ, Riley KJ. Thymidine kinase 1 as a molecular target for boron neutron capture therapy of brain tumors. Proceedings of the National Academy of Sciences of the United States of America. 105: 17493-7. PMID 18981415 DOI: 10.1073/Pnas.0809569105  0.45
2007 Rousseau J, Boudou C, Barth RF, Balosso J, Estève F, Elleaume H. Enhanced survival and cure of F98 glioma-bearing rats following intracerebral delivery of carboplatin in combination with photon irradiation. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 5195-201. PMID 17726137 DOI: 10.1158/1078-0432.CCR-07-1002  0.328
2006 Byun Y, Thirumamagal BTS, Yang W, Eriksson S, Barth RF, Tjarks W. Preparation and biological evaluation of 10B-enriched 3-[5-{2-(2,3-dihydroxyprop-1-yl)-o-carboran-1-yl}pentan-1-yl]thymidine (N5-2OH), a new boron delivery agent for boron neutron capture therapy of brain tumors Journal of Medicinal Chemistry. 49: 5513-5523. PMID 16942024 DOI: 10.1021/jm060413w  0.337
2006 Yang W, Barth RF, Wu G, Kawabata S, Sferra TJ, Bandyopadhyaya AK, Tjarks W, Ferketich AK, Moeschberger ML, Binns PJ, Riley KJ, Coderre JA, Ciesielski MJ, Fenstermaker RA, Wikstrand CJ. Molecular targeting and treatment of EGFRvIII-positive gliomas using boronated monoclonal antibody L8A4. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 12: 3792-802. PMID 16778107 DOI: 10.1158/1078-0432.Ccr-06-0141  0.441
2006 Wu G, Barth RF, Yang W, Lee RJ, Tjarks W, Backer MV, Backer JM. Boron containing macromolecules and nanovehicles as delivery agents for neutron capture therapy. Anti-Cancer Agents in Medicinal Chemistry. 6: 167-84. PMID 16529539 DOI: 10.2174/187152006776119153  0.367
2006 Wu G, Barth RF, Yang W, Kawabata S, Zhang L, Green-Church K. Targeted delivery of methotrexate to epidermal growth factor receptor-positive brain tumors by means of cetuximab (IMC-C225) dendrimer bioconjugates. Molecular Cancer Therapeutics. 5: 52-9. PMID 16432162 DOI: 10.1158/1535-7163.MCT-05-0325  0.377
2005 Yang W, Barth RF, Wu G, Ciesielski MJ, Fenstermaker RA, Moffat BA, Ross BD, Wikstrand CJ. Development of a syngeneic rat brain tumor model expressing EGFRvIII and its use for molecular targeting studies with monoclonal antibody L8A4. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 11: 341-50. PMID 15671565  0.394
2004 Yang W, Barth RF, Wu G, Bandyopadhyaya AK, Thirumamagal BT, Tjarks W, Binns PJ, Riley K, Patel H, Coderre JA, Ciesielski MJ, Fenstermaker RA. Boronated epidermal growth factor as a delivery agent for neutron capture therapy of EGF receptor positive gliomas. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 61: 981-5. PMID 15308179 DOI: 10.1016/j.apradiso.2004.05.071  0.382
2004 Barth RF, Wu G, Yang W, Binns PJ, Riley KJ, Patel H, Coderre JA, Tjarks W, Bandyopadhyaya AK, Thirumamagal BT, Ciesielski MJ, Fenstermaker RA. Neutron capture therapy of epidermal growth factor (+) gliomas using boronated cetuximab (IMC-C225) as a delivery agent. Applied Radiation and Isotopes : Including Data, Instrumentation and Methods For Use in Agriculture, Industry and Medicine. 61: 899-903. PMID 15308165 DOI: 10.1016/j.apradiso.2004.05.004  0.361
2004 Wu G, Barth RF, Yang W, Chatterjee M, Tjarks W, Ciesielski MJ, Fenstermaker RA. Site-specific conjugation of boron-containing dendrimers to anti-EGF receptor monoclonal antibody cetuximab (IMC-C225) and its evaluation as a potential delivery agent for neutron capture therapy. Bioconjugate Chemistry. 15: 185-94. PMID 14733599 DOI: 10.1021/bc0341674  0.406
2004 Barth RF, Grecula JC, Yang W, Rotaru JH, Nawrocky M, Gupta N, Albertson BJ, Ferketich AK, Moeschberger ML, Coderre JA, Rofstad EK. Combination of boron neutron capture therapy and external beam radiotherapy for brain tumors. International Journal of Radiation Oncology, Biology, Physics. 58: 267-77. PMID 14697448 DOI: 10.1016/S0360-3016(03)01613-4  0.47
2003 Stephenson SM, Yang W, Stevens PJ, Tjarks W, Barth RF, Lee RJ. Folate receptor-targeted liposomes as possible delivery vehicles for boron neutron capture therapy. Anticancer Research. 23: 3341-5. PMID 12926073  0.325
2003 Gibson CR, Staubus AE, Barth RF, Yang W, Ferketich AK, Moeschberger MM. Pharmacokinetics of sodium borocaptate: A critical assessment of dosing paradigms for boron neutron capture therapy Journal of Neuro-Oncology. 62: 157-169. PMID 12749711 DOI: 10.1007/Bf02699942  0.326
2003 Barth RF, Yang W, Coderre JA. Rat brain tumor models to assess the efficacy of boron neutron capture therapy: a critical evaluation. Journal of Neuro-Oncology. 62: 61-74. PMID 12749703  0.534
2003 Barth RF. A critical assessment of boron neutron capture therapy: an overview. Journal of Neuro-Oncology. 62: 1-5. PMID 12749698  0.323
2003 Roychowdhury S, Peng R, Baiocchi RA, Bhatt D, Vourganti S, Grecula J, Gupta N, Eisenbeis CF, Nuovo GJ, Yang W, Schmalbrock P, Ferketich A, Moeschberger M, Porcu P, Barth RF, et al. Experimental treatment of Epstein-Barr virus-associated primary central nervous system lymphoma. Cancer Research. 63: 965-71. PMID 12615710  0.33
2002 Yang W, Barth RF, Adams DM, Ciesielski MJ, Fenstermaker RA, Shukla S, Tjarks W, Caligiuri MA. Convection-enhanced delivery of boronated epidermal growth factor for molecular targeting of EGF receptor-positive gliomas. Cancer Research. 62: 6552-8. PMID 12438250  0.36
2002 Barth RF, Yang W, Adams DM, Rotaru JH, Shukla S, Sekido M, Tjarks W, Fenstermaker RA, Ciesielski M, Nawrocky MM, Coderre JA. Molecular targeting of the epidermal growth factor receptor for neutron capture therapy of gliomas. Cancer Research. 62: 3159-66. PMID 12036929  0.398
2002 Barth RF, Yang W, Bartus RT, Rotaru JH, Ferketich AK, Moeschberger ML, Nawrocky MM, Coderre JA, Rofstad EK. Neutron capture therapy of intracerebral melanoma: enhanced survival and cure after blood-brain barrier opening to improve delivery of boronophenylalanine. International Journal of Radiation Oncology, Biology, Physics. 52: 858-68. PMID 11849812 DOI: 10.1016/S0360-3016(01)02734-1  0.531
2001 Yang W, Barth RF, Leveille R, Adams DM, Ciesielski M, Fenstermaker RA, Capala J. Evaluation of systemically administered radiolabeled epidermal growth factor as a brain tumor targeting agent. Journal of Neuro-Oncology. 55: 19-28. PMID 11804279 DOI: 10.1023/A:1013017821166  0.446
2000 Yang W, Barth RF, Rotaru JH, Boesel CP, Wilkie DA, Bresnahan JC, Hadjiconstantinou M, Goettl VM, Joel DD, Nawrocky MM. Boron neutron capture therapy of brain tumors: functional and neuropathologic effects of blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine. Journal of Neuro-Oncology. 48: 179-90. PMID 11100816 DOI: 10.1023/A:1006410611067  0.489
2000 Goodman JH, Yang W, Barth RF, Gao Z, Boesel CP, Staubus AE, Gupta N, Gahbauer RA, Adams DM, Gibson CR, Ferketich AK, Moeschberger ML, Soloway AH, Carpenter DE, Albertson BJ, et al. Boron neutron capture therapy of brain tumors: biodistribution, pharmacokinetics, and radiation dosimetry sodium borocaptate in patients with gliomas. Neurosurgery. 47: 608-21; discussion 6. PMID 10981748 DOI: 10.1097/00006123-200009000-00016  0.391
2000 Yang W, Barth RF, Bartus RT, Rotaru JH, Moeschberger ML, Ferketich AK, Nawrocky MM, Coderre JA, Goodman JH. Improved survival after boron neutron capture therapy of brain tumors by Cereport-mediated blood-brain barrier modulation to enhance delivery of boronophenylalanine. Neurosurgery. 47: 189-97; discussion 1. PMID 10917362 DOI: 10.1097/00006123-200007000-00039  0.533
2000 Barth RF, Yang W, Rotaru JH, Moeschberger ML, Boesel CP, Soloway AH, Joel DD, Nawrocky MM, Ono K, Goodman JH. Boron neutron capture therapy of brain tumors: enhanced survival and cure following blood-brain barrier disruption and intracarotid injection of sodium borocaptate and boronophenylalanine. International Journal of Radiation Oncology, Biology, Physics. 47: 209-18. PMID 10758326 DOI: 10.1016/S0360-3016(00)00421-1  0.522
1999 Barth RF, Yang W, Bartus RT, Moeschberger ML, Goodman JH. Enhanced delivery of boronophenylalanine for neutron capture therapy of brain tumors using the bradykinin analog Cereport (Receptor-Mediated Permeabilizer-7). Neurosurgery. 44: 351-9; discussion 35. PMID 9932889 DOI: 10.1097/00006123-199902000-00062  0.517
1998 Barth RF. Rat brain tumor models in experimental neuro-oncology: the 9L, C6, T9, F98, RG2 (D74), RT-2 and CNS-1 gliomas. Journal of Neuro-Oncology. 36: 91-102. PMID 9525831 DOI: 10.1023/A:1005805203044  0.419
1997 Capala J, Barth RF, Bailey MQ, Fenstermaker RA, Marek MJ, Rhodes BA. Radiolabeling of epidermal growth factor with 99mTc and in vivo localization following intracerebral injection into normal and glioma-bearing rats. Bioconjugate Chemistry. 8: 289-95. PMID 9177833 DOI: 10.1021/BC970031S  0.401
1997 Yang W, Barth RF, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH. Enhanced survival of glioma bearing rats following boron neutron capture therapy with blood-brain barrier disruption and intracarotid injection of boronophenylalanine. Journal of Neuro-Oncology. 33: 59-70. PMID 9151224 DOI: 10.1023/A:1005769214899  0.506
1997 Soloway AH, Barth RF, Gahbauer RA, Blue TE, Goodman JH. The rationale and requirements for the development of boron neutron capture therapy of brain tumors. Journal of Neuro-Oncology. 33: 9-18. PMID 9151219 DOI: 10.1023/A:1005753610355  0.313
1997 Barth RF, Soloway AH. Boron neutron capture therapy of brain tumors--current status and future prospects. Journal of Neuro-Oncology. 33: 3-7. PMID 9151218 DOI: 10.1023/A:1005783531660  0.381
1997 Yang W, Barth RF, Rotaru JH, Moeschberger ML, Joel DD, Nawrocky MM, Goodman JH, Soloway AH. Boron neutron capture therapy of brain tumors: enhanced survival following intracarotid injection of sodium borocaptate with or without blood-brain barrier disruption. International Journal of Radiation Oncology, Biology, Physics. 37: 663-72. PMID 9112465 DOI: 10.1016/S0360-3016(96)00082-X  0.506
1996 Barth RF, Soloway AH, Brugger RM. Boron neutron capture therapy of brain tumors: past history, current status, and future potential. Cancer Investigation. 14: 534-50. PMID 8951358 DOI: 10.3109/07357909609076899  0.348
1996 Capala J, Barth RF, Bendayan M, Lauzon M, Adams DM, Soloway AH, Fenstermaker RA, Carlsson J. Boronated epidermal growth factor as a potential targeting agent for boron neutron capture therapy of brain tumors. Bioconjugate Chemistry. 7: 7-15. PMID 8741985 DOI: 10.1021/bc950077q  0.302
1996 Yang W, Barth RF, Carpenter DE, Moeschberger ML, Goodman JH. Enhanced delivery of boronophenylalanine for neutron capture therapy by means of intracarotid injection and blood-brain barrier disruption. Neurosurgery. 38: 985-92. PMID 8727825 DOI: 10.1097/00006123-199605000-00027  0.459
1994 Matalka KZ, Barth RF, Staubus AE, Moeschberger ML, Coderre JA. Neutron capture therapy of a rat glioma using boronophenylalanine as a capture agent Radiation Research. 137: 44-51. PMID 8265787 DOI: 10.2307/3578789  0.476
1994 Barth RF, Matalka KZ, Bailey MQ, Staubus AE, Soloway AH, Moeschberger ML, Coderre JA, Rofstad EK. A nude rat model for neutron capture therapy of human intracerebral melanoma International Journal of Radiation Oncology, Biology, Physics. 28: 1079-1088. PMID 8175392 DOI: 10.1016/0360-3016(94)90481-2  0.449
1994 Barth RF, Soloway AH. Boron neutron capture therapy of primary and metastatic brain tumors. Molecular and Chemical Neuropathology. 21: 139-54. PMID 8086033 DOI: 10.1007/BF02815348  0.41
1990 Clendenon NR, Barth RF, Gordon WA, Goodman JH, Alam F, Staubus AE, Boesel CP, Yates AJ, Moeschberger ML, Fairchild RG. Boron neutron capture therapy of a rat glioma. Neurosurgery. 26: 47-55. PMID 2294479 DOI: 10.1097/00006123-199001000-00007  0.476
1990 Goodman JH, McGregor JM, Clendenon NR, Gahbauer RA, Barth RF, Soloway AH, Fairchild RG. Inhibition of tumor growth in a glioma model treated with boron neutron capture therapy. Neurosurgery. 27: 383-8. PMID 2234330 DOI: 10.1097/00006123-199009000-00007  0.416
1989 Goodman JH, McGregor JM, Clendenon NR, Gahbauer RA, Barth RF, Soloway AH, Fairchild RG. Ultrastructural microvascular response to boron neutron capture therapy in an experimental model. Neurosurgery. 24: 701-8. PMID 2716978 DOI: 10.1227/00006123-198905000-00007  0.407
Show low-probability matches.